생체전기의료 시장 : 제품 유형, 적응증, 최종 사용자별 - 세계 예측(2025-2030년)

The Bioelectric Medicine Market was valued at USD 23.83 billion in 2023, expected to reach USD 26.74 billion in 2024, and is projected to grow at a CAGR of 12.29%, to USD 53.66 billion by 2030.

Bioelectric medicine, a burgeoning field at the intersection of bioengineering, neurology, and advanced medical technologies, harnesses electrical impulses to modulate nervous system activity for therapeutic purposes. Its scope involves developing implantable and non-invasive devices that target specific neural pathways to treat a range of conditions such as chronic pain, epilepsy, depression, and inflammatory diseases. The necessity of bioelectric medicine lies in its potential to offer alternative or complementary solutions to pharmacological treatments, which often have side effects or limited efficacy. Applications span across cardiology, neurology, and pain management, while the end-use scope includes hospitals, specialized clinics, and home healthcare settings, driven by the increasing demand for non-pharmacological treatment options.

Key growth factors in the bioelectric medicine market include the rising prevalence of chronic diseases, advancements in neuromodulation technologies, and increased investment in research and development. As healthcare systems globally seek efficiency, bioelectric medicine offers cost-effective, targeted therapies, fostering demand. Potential opportunities lie in expanding the scope of wearable bioelectronic devices and personalized treatment protocols. There's significant scope for innovation in developing miniaturized, energy-efficient devices and leveraging artificial intelligence for precision therapy. Collaborations between biomedical firms and academic institutions can catalyze breakthroughs, while regulatory bodies refining approval pathways for medical devices could accelerate market entry.

However, market growth is challenged by high development costs, complex regulatory frameworks, and the need for extensive clinical trials to establish efficacy and safety. Reimbursement issues and limited awareness also pose hurdles. To overcome these challenges, companies should focus on comprehensive clinical evidence generation and proactive stakeholder engagement. Investing in educational campaigns to raise awareness about bioelectric therapy benefits could drive adoption. Ultimately, innovations in bioelectric medicine could dramatically reshape therapeutic strategies across multiple domains, emphasizing the need for ongoing R&D to unlock the sector's full potential and sustain competitive advantage. Collaboration, regulatory navigation, and strategic marketing will be crucial in overcoming barriers and capturing emerging opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bioelectric Medicine Market

The Bioelectric Medicine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing frequency of chronic diseases among population
  • Growing infrastructure expenditure in healthcare sector in developing economies
  • Rising incidences of Parkinson's disease in aging population
• Market Restraints
  • High costs associated with manufacturing of bioelectric medical devices
• Market Opportunities
  • Advanced innovations in development of novel bioelectric medicine
  • Rising rate of regulatory approval for bioelectric medicines
• Market Challenges
  • Stern government rules and regulations for the development and production of medical devices

Porter's Five Forces: A Strategic Tool for Navigating the Bioelectric Medicine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bioelectric Medicine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bioelectric Medicine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bioelectric Medicine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bioelectric Medicine Market

A detailed market share analysis in the Bioelectric Medicine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bioelectric Medicine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bioelectric Medicine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bioelectric Medicine Market

A strategic analysis of the Bioelectric Medicine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bioelectric Medicine Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aleva Neurotherapeutics SA, BioMed Central Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, CEFALY Technology sprl, ElectroCore, Inc., General Electric Company, LivaNova PLC, MED-EL Elektromedizinische Gerate Gesellschaft m.b.H., Medtronic PLC, NeuroSigma, Inc., Nevro Corp., Oticon Medical A/S by Cochlear Ltd, Renishaw PLC, ReShape Lifesciences, Inc., Siemens Healthineers AG, Sonova Holding AG, and Vomaris Innovations, Inc..

Market Segmentation & Coverage

This research report categorizes the Bioelectric Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Cardiac Pacemakers, Cochlear Implants, Deep Brain Stimulators, Implantable Cardioverter Defibrillators, Sacral Nerve Stimulators, Spinal Cord Stimulators, Transcutaneous Electrical Nerve Stimulators, and Vagus Nerve Stimulators.
• Based on Type, market is studied across Implantable Electroceutical Devices and Noninvasive Electroceutical Devices.
• Based on Indication, market is studied across Arrhythmia, Chronic Pain, Depression, Epilepsy, Parkinson's Disease, Tremor, and Urinary & Fecal Incontinence.
• Based on End-User, market is studied across Hospitals and Pharmaceutical Research.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing frequency of chronic diseases among population
    • 5.1.1.2. Growing infrastructure expenditure in healthcare sector in developing economies
    • 5.1.1.3. Rising incidences of Parkinson's disease in aging population
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with manufacturing of bioelectric medical devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Advanced innovations in development of novel bioelectric medicine
    • 5.1.3.2. Rising rate of regulatory approval for bioelectric medicines
  • 5.1.4. Challenges
    • 5.1.4.1. Stern government rules and regulations for the development and production of medical devices
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Bioelectric Medicine Market, by Product

• 6.1. Introduction
• 6.2. Cardiac Pacemakers
• 6.3. Cochlear Implants
• 6.4. Deep Brain Stimulators
• 6.5. Implantable Cardioverter Defibrillators
• 6.6. Sacral Nerve Stimulators
• 6.7. Spinal Cord Stimulators
• 6.8. Transcutaneous Electrical Nerve Stimulators
• 6.9. Vagus Nerve Stimulators

7. Bioelectric Medicine Market, by Type

• 7.1. Introduction
• 7.2. Implantable Electroceutical Devices
• 7.3. Noninvasive Electroceutical Devices

8. Bioelectric Medicine Market, by Indication

• 8.1. Introduction
• 8.2. Arrhythmia
• 8.3. Chronic Pain
• 8.4. Depression
• 8.5. Epilepsy
• 8.6. Parkinson's Disease
• 8.7. Tremor
• 8.8. Urinary & Fecal Incontinence

9. Bioelectric Medicine Market, by End-User

• 9.1. Introduction
• 9.2. Hospitals
• 9.3. Pharmaceutical Research

10. Americas Bioelectric Medicine Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Bioelectric Medicine Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Bioelectric Medicine Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Aleva Neurotherapeutics SA
• 3. BioMed Central Ltd.
• 4. Biotronik SE & Co. KG
• 5. Boston Scientific Corporation
• 6. CEFALY Technology sprl
• 7. ElectroCore, Inc.
• 8. General Electric Company
• 9. LivaNova PLC
• 10. MED-EL Elektromedizinische Gerate Gesellschaft m.b.H.
• 11. Medtronic PLC
• 12. NeuroSigma, Inc.
• 13. Nevro Corp.
• 14. Oticon Medical A/S by Cochlear Ltd
• 15. Renishaw PLC
• 16. ReShape Lifesciences, Inc.
• 17. Siemens Healthineers AG
• 18. Sonova Holding AG
• 19. Vomaris Innovations, Inc.